Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens.

Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, Liu M, Zhang N, Wang S, Angenieux B, Panosyan E, Samuels ER, Park J, Williams D, Konkankit V, Nathanson D, van Dam RM, Phelps ME, Wu H, Liau LM, Mischel PS, Lazareff JA, Kornblum HI, Yong WH, Graeber TG, Tseng HR.

Cancer Res. 2010 Aug 1;70(15):6128-38. doi: 10.1158/0008-5472.CAN-10-0076. Epub 2010 Jul 14.

3.

New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.

Albert S, Serova M, Dreyer C, Sablin MP, Faivre S, Raymond E.

Expert Opin Investig Drugs. 2010 Aug;19(8):919-30. doi: 10.1517/13543784.2010.499121. Review.

PMID:
20569080
4.
5.

mTOR signaling in glioblastoma: lessons learned from bench to bedside.

Akhavan D, Cloughesy TF, Mischel PS.

Neuro Oncol. 2010 Aug;12(8):882-9. doi: 10.1093/neuonc/noq052. Epub 2010 May 14. Review.

6.

Using a microfluidic device for high-content analysis of cell signaling.

Cheong R, Wang CJ, Levchenko A.

Sci Signal. 2009 Jun 16;2(75):pl2. doi: 10.1126/scisignal.275pl2. Review.

7.

Current Advances in Highly Multiplexed Antibody-Based Single-Cell Proteomic Measurements.

Huang L, Michael SA, Chen Y, Wu H.

Chem Asian J. 2017 Jul 18;12(14):1680-1691. doi: 10.1002/asia.201700404. Epub 2017 Jun 13. Review.

PMID:
28493387

Supplemental Content

Support Center